EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62017TN0261
Case T-261/17: Action brought on 5 May 2017 — Bayer v EUIPO — UNI — Pharma (SALOSPIR)
Case T-261/17: Action brought on 5 May 2017 — Bayer v EUIPO — UNI — Pharma (SALOSPIR)
Case T-261/17: Action brought on 5 May 2017 — Bayer v EUIPO — UNI — Pharma (SALOSPIR)
OJ C 221, 10.7.2017, p. 34–35
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
10.7.2017 |
EN |
Official Journal of the European Union |
C 221/34 |
Action brought on 5 May 2017 — Bayer v EUIPO — UNI — Pharma (SALOSPIR)
(Case T-261/17)
(2017/C 221/48)
Language in which the application was lodged: English
Parties
Applicant: Bayer AG (Leverkusen, Germany) (represented by: V. von Bomhard, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: UNI — Pharma Kleon Tsetis Pharmaceutical Laboratories Industrial and Commercial SA (Kifisia, Greece)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU figurative mark containing the word element ‘SALOSPIR’ — Application for registration No 12 351 458
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 17 February 2017 in Case R 2444/2015-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO and Uni-Pharma, if the latter makes use of its right to join the proceedings as an intervener, to pay the costs. |
Plea in law
|
— |
Infringement of Articles 8(1)(b), 8(4) and 8(5) of Regulation No 207/2009. |